Eli Casdin's Net Worth

$374 Million

Estimate Recalculated Feb 28, 2024 07:40PM EST

Who is Eli Casdin?

Eli Casdin has an estimated net worth of $374 Million. This is based on reported shares across multiple companies, which include CONSTELLATION PHARMACEUTICALS INC, Fulcrum Therapeutics, Inc., BIOLIFE SOLUTIONS INC, MAXCYTE, INC., Generation Bio Co., Tenaya Therapeutics, Inc., STANDARD BIOTOOLS INC., SomaLogic, Inc., EXACT SCIENCES CORP, Absci Corp, Century Therapeutics, Inc., GeneDx Holdings Corp., and EQRx, Inc..

SEC CIK

Eli Casdin's CIK is 0001534264

Past Insider Trading and Trends

2021 was Eli Casdin's most active year for acquiring shares with 37 total transactions. Eli Casdin's most active month to acquire stocks was the month of June. 2021 was Eli Casdin's most active year for disposing of shares, totalling 15 transactions. Eli Casdin's most active month to dispose stocks was the month of June. 2021 saw Eli Casdin paying a total of $201,150,000.00 for 188,940,443 shares, this is the most they've acquired in one year. In 2022 Eli Casdin cashed out on 3,984,170 shares for a total of $18,437,940.30, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

STANDARD BIOTOOLS INC. (LAB) Snapshot price: $2.345

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+28.23%
22.8K
$2.50
$57,000.00
103.56K
Feb 20
Form 4
+29,458.26%
21.55M
21.62M
Jan 5
Form 4
+56.40%
26.38K
73.14K
Jun 14
Form 4
1.2M
$2.19
$2,631,335.00
1.2M
May 17 - May 19
Form 4
+195.02%
30.91K
46.77K
Jun 15
Form 4
15.85K
15.85K
Apr 4
Form 3
0
0
No matching records found

SomaLogic, Inc. (SLGC) No price found

Chief Executive Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-19.41M
0
Jan 5
Form 4
+100.00%
3.43K
6.86K
Mar 17
Form 4
+2.17%
215.19K
10.13M
Sep 29
Form 4
3.43K
3.43K
Mar 1
Form 4
0
0
Oct 27
Form 4
+81.69%
19.19M
$10.00
$25,000,000.00
42.68M
Sep 1
Form 3
0
0
No matching records found

CONSTELLATION PHARMACEUTICALS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
771.41K
$15.00
771.41K
Jul 23
Form 3
0
0
No matching records found

Fulcrum Therapeutics, Inc. (FULC) Snapshot price: $7.985

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
604.28K
$15.84
604.28K
Jul 22
Form 3
0
0
No matching records found

EXACT SCIENCES CORP (EXAS) Snapshot price: $61.28

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+40.85%
2.56K
8.82K
Jul 23
Form 4
450
450
Nov 8
Form 4
0
0
Jul 25
Form 4
6.26K
6.26K
Jul 26
Form 4
0
0
Oct 26
Form 3
0
0
No matching records found